Literature DB >> 21116448

Selective Modulation of Gq/Gs pathways by Naphtho Pyrano Pyrimidines as antagonists of the Neuropeptide S Receptor.

Joshua G McCoy1, Juan J Marugan, Ke Liu, Wei Zheng, Noel Southall, Wenwei Huang, Markus Heilig, Christopher P Austin.   

Abstract

Antagonists of the Neuropeptide S Receptor have been postulated as promising therapeutics in the treatment of respiratory, sleep, anxiety, and addictive disorders. Here we present the SAR of a new series of orthosteric antagonists. Neuropeptide S Receptor signaling is coupled to both Gq and Gs proteins, and we observe that different analogues in this structural series can selectively antagonize these two pathways. Many G-protein coupled receptors transduce signals through multiple pathways. Selective antagonism of these pathways may lead the way to the development of more targeted pharmacological profiles and therapies.

Entities:  

Year:  2010        PMID: 21116448      PMCID: PMC2992437          DOI: 10.1021/cn100040h

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  13 in total

1.  Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor.

Authors:  Naoe Okamura; Stephen A Habay; Joanne Zeng; A Richard Chamberlin; Rainer K Reinscheid
Journal:  J Pharmacol Exp Ther       Date:  2008-03-12       Impact factor: 4.030

Review 2.  Neuropeptide S as a novel arousal promoting peptide transmitter.

Authors:  Rainer K Reinscheid; Yan-Ling Xu
Journal:  FEBS J       Date:  2005-11       Impact factor: 5.542

3.  A multiplex calcium assay for identification of GPCR agonists and antagonists.

Authors:  Ke Liu; Noel Southall; Steve A Titus; James Inglese; Robert L Eskay; Paul Shinn; Christopher P Austin; Markus A Heilig; Wei Zheng
Journal:  Assay Drug Dev Technol       Date:  2010-06       Impact factor: 1.738

4.  Characterization of a common susceptibility locus for asthma-related traits.

Authors:  Tarja Laitinen; Anne Polvi; Pia Rydman; Johanna Vendelin; Ville Pulkkinen; Paula Salmikangas; Siru Mäkelä; Marko Rehn; Asta Pirskanen; Anna Rautanen; Marco Zucchelli; Harriet Gullstén; Marina Leino; Harri Alenius; Tuula Petäys; Tari Haahtela; Annika Laitinen; Catherine Laprise; Thomas J Hudson; Lauri A Laitinen; Juha Kere
Journal:  Science       Date:  2004-04-09       Impact factor: 47.728

5.  Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.

Authors:  Yan-Ling Xu; Rainer K Reinscheid; Salvador Huitron-Resendiz; Stewart D Clark; Zhiwei Wang; Steven H Lin; Fernando A Brucher; Joanne Zeng; Nga K Ly; Steven J Henriksen; Luis de Lecea; Olivier Civelli
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

6.  Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.

Authors:  Remo Guerrini; Valeria Camarda; Claudio Trapella; Girolamo Caló; Anna Rizzi; Chiara Ruzza; Stella Fiorini; Erika Marzola; Rainer K Reinscheid; Domenico Regoli; Severo Salvadori
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

7.  Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice.

Authors:  A Rizzi; R Vergura; G Marzola; C Ruzza; R Guerrini; S Salvadori; D Regoli; G Calo
Journal:  Br J Pharmacol       Date:  2008-03-31       Impact factor: 8.739

8.  In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.

Authors:  Valeria Camarda; Anna Rizzi; Chiara Ruzza; Silvia Zucchini; Giuliano Marzola; Erika Marzola; Remo Guerrini; Severo Salvadori; Rainer K Reinscheid; Domenico Regoli; Girolamo Calò
Journal:  J Pharmacol Exp Ther       Date:  2008-10-29       Impact factor: 4.030

9.  Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.

Authors:  Sarah K Leonard; Jason M Dwyer; Stacey J Sukoff Rizzo; Brian Platt; Sheree F Logue; Sarah J Neal; Jessica E Malberg; Chad E Beyer; Lee E Schechter; Sharon Rosenzweig-Lipson; Robert H Ring
Journal:  Psychopharmacology (Berl)       Date:  2008-03-03       Impact factor: 4.530

10.  Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for Neuropeptide S antagonist activity.

Authors:  Yanan Zhang; Brian P Gilmour; Hernán A Navarro; Scott P Runyon
Journal:  Bioorg Med Chem Lett       Date:  2008-06-12       Impact factor: 2.823

View more
  6 in total

1.  Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.

Authors:  Samarjit Patnaik; Juan J Marugan; Ke Liu; Wei Zheng; Noel Southall; Seameen J Dehdashti; Annika Thorsell; Markus Heilig; Lauren Bell; Michelle Zook; Bob Eskay; Kyle R Brimacombe; Christopher P Austin
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

Review 2.  Medications development to treat alcohol dependence: a vision for the next decade.

Authors:  Raye Z Litten; Mark Egli; Markus Heilig; Changhai Cui; Joanne B Fertig; Megan L Ryan; Daniel E Falk; Howard Moss; Robert Huebner; Antonio Noronha
Journal:  Addict Biol       Date:  2012-03-28       Impact factor: 4.280

3.  The reaction of 2-amino-4H-pyrans with N-bromosuccinimide.

Authors:  Abdelouahid Samadi; Daniel Silva; Mourad Chioua; Lourdes Infantes; Elena Soriano; José Marco-Contelles
Journal:  Mol Divers       Date:  2014-12-14       Impact factor: 2.943

4.  A novel brain penetrant NPS receptor antagonist, NCGC00185684, blocks alcohol-induced ERK-phosphorylation in the central amygdala and decreases operant alcohol self-administration in rats.

Authors:  Annika Thorsell; Jenica D Tapocik; Ke Liu; Michelle Zook; Lauren Bell; Meghan Flanigan; Samarjit Patnaik; Juan Marugan; Ruslan Damadzic; Seameen J Dehdashti; Melanie L Schwandt; Noel Southall; Christopher P Austin; Robert Eskay; Roberto Ciccocioppo; Wei Zheng; Markus Heilig
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

5.  Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.

Authors:  Jingbo Xiao; Zaohua Huang; Catherine Z Chen; Irina U Agoulnik; Noel Southall; Xin Hu; Raisa E Jones; Marc Ferrer; Wei Zheng; Alexander I Agoulnik; Juan J Marugan
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative Agents.

Authors:  Ayesha Zafar; Suat Sari; Euphemia Leung; Lisa I Pilkington; Michelle van Rensburg; David Barker; Jóhannes Reynisson
Journal:  Molecules       Date:  2017-12-18       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.